A detailed history of Ars Wealth Advisors Group, LLC transactions in Abbott Laboratories stock. As of the latest transaction made, Ars Wealth Advisors Group, LLC holds 6,319 shares of ABT stock, worth $740,965. This represents 0.09% of its overall portfolio holdings.

Number of Shares
6,319
Previous 6,218 1.62%
Holding current value
$740,965
Previous $646,000 11.46%
% of portfolio
0.09%
Previous 0.08%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 15, 2024

BUY
$100.07 - $118.13 $10,107 - $11,931
101 Added 1.62%
6,319 $720,000
Q2 2024

Jul 19, 2024

BUY
$100.73 - $112.44 $35,356 - $39,466
351 Added 5.98%
6,218 $646,000
Q1 2024

May 13, 2024

BUY
$109.52 - $120.96 $94,734 - $104,630
865 Added 17.29%
5,867 $666,000
Q4 2023

Feb 06, 2024

BUY
$90.19 - $110.4 $79,006 - $96,710
876 Added 21.23%
5,002 $550,000
Q3 2023

Oct 26, 2023

SELL
$95.53 - $114.62 $115,304 - $138,346
-1,207 Reduced 22.63%
4,126 $399,000
Q2 2023

Jul 18, 2023

BUY
$100.78 - $112.29 $537,459 - $598,842
5,333 New
5,333 $581,000
Q4 2022

Feb 13, 2023

BUY
$95.06 - $111.52 $20,247 - $23,753
213 Added 4.99%
4,482 $492,000
Q3 2022

Nov 14, 2022

BUY
$96.76 - $112.03 $413,068 - $478,256
4,269 New
4,269 $413,000
Q3 2022

Nov 08, 2022

SELL
$96.76 - $112.03 $398,264 - $461,115
-4,116 Closed
0 $413,000
Q2 2022

Aug 15, 2022

SELL
$102.07 - $123.37 $66,855 - $80,807
-655 Reduced 13.73%
4,116 $447,000
Q1 2022

May 12, 2022

SELL
$114.02 - $139.04 $34,776 - $42,407
-305 Reduced 6.01%
4,771 $565,000
Q4 2021

Feb 08, 2022

BUY
$115.53 - $141.46 $12,939 - $15,843
112 Added 2.26%
5,076 $714,000
Q3 2021

Oct 26, 2021

BUY
$116.66 - $129.06 $579,100 - $640,653
4,964 New
4,964 $586,000

Others Institutions Holding ABT

About ABBOTT LABORATORIES


  • Ticker ABT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,751,219,968
  • Market Cap $205B
  • Description
  • Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...
More about ABT
Track This Portfolio

Track Ars Wealth Advisors Group, LLC Portfolio

Follow Ars Wealth Advisors Group, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ars Wealth Advisors Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Ars Wealth Advisors Group, LLC with notifications on news.